Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

An Innovative Approach to the Formulation of Biobetters

A hydrogel depot formulation platform is well suited to the formulation of biobetter products both original biologics and biosimilars as no chemical modification is required and so development is relatively straightforward from a clinical and regulatory perspective.

Jean Chatellier, Flamel Technologies (March 2012)

Keywords: Biobetter Biosimilar Life-cycle management Hydrogel depot formulation Human growth hormone Human glucagon-like peptide-1

    View full article    |    Back to Delivery systems section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |